Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David J Sullivan, MD
The Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Center for American Indian Health - Chinle Office
Chinle, Arizona, United States
- Mayo Clinic, Phoenix
Phoenix, Arizona, United States
- University of Arizona, Phoenix
Tucson, Arizona, United States
- University of Arizona, Tuscon
Tucson, Arizona, United States
- Center for American Indian Health - Whiteriver Office
Whiteriver, Arizona, United States
- University of California, Los Angeles
Los Angeles, California, United States
- University of California, Irvine Health
Orange, California, United States
- Western Connecticut Health Network, Danbury Hospital
Danbury, Connecticut, United States
- Western Connecticut Health Network, Norwalk Hospital
Norwalk, Connecticut, United States
- University of Miami
Coral Gables, Florida, United States
- University of Miami Clinical Translational Research Site
Miami, Florida, United States
- Northshore University Healthsystem
Evanston, Illinois, United States
- Tulane University
New Orleans, Louisiana, United States
- Anne Arundel Medical Center
Annapolis, Maryland, United States
- the Johns Hopkins University
Baltimore, Maryland, United States
- Medstar Washington Hospital Center
Hyattsville, Maryland, United States
- University of Massachusetts Worcester
Worcester, Massachusetts, United States
- Wayne State University
Detroit, Michigan, United States
- University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
- Center for American Indian Health - Gallup Office
Gallup, New Mexico, United States
- Center for American Indian Health - Shiprock Office
Shiprock, New Mexico, United States
- Vassar Brothers Medical Center
Poughkeepsie, New York, United States
- University of Rochester
Rochester, New York, United States
- University of Cincinnati Medical Center
Cincinnati, Ohio, United States
- Lifespan/brownuniversity (rhode Island Hospital)
Providence, Rhode Island, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Texas Health Science Center at Houston
Houston, Texas, United States
- the University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jun 2020
- Primary completion
- 14 Jan 2022
- Completion
- 14 Dec 2022
- Last update posted
- 2 Jun 2023
- Registered enrollment
- 1,225
- Registry id
- NCT04373460
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.